Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATTENTION LATE
NCT05701956Phase 3Completed
- Sponsor
- The First Affiliated Hospital of University of Science and Technology of China
- Start
- Mar 2023
- Primary completion
- Feb 2025
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of tenecteplase in ischemic stroke, basilar artery occlusion (BAO), sponsored by The First Affiliated Hospital of University of Science and Technology of China. Started Mar 2023; status: completed.
02
Drugs
tenecteplase
03
Conditions
ischemic strokebasilar artery occlusion (BAO)
Beyond the preview
Go deeper on NCT05701956.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05701956.